LAMEA Intravenous (IV) Therapy and Vein Access Market Size, Share & Industry Trends Analysis Report By End User (Hospitals, Ambulatory Surgical Center, and Clinics), By Application, By Type, By Country and Growth Forecast, 2022-2028

The Latin America, Middle East and Africa Intravenous (IV) Therapy and Vein Access Market is expected to witness market growth of 7.8% CAGR during the forecast period (2022-2028).

IV therapy is advantageous for a variety of reasons, one of which is the ease with which it can be administered. If the patient does not want to go to the hospital, IV therapy is a simple and handy option. A person can eliminate unnecessary travel by opting for in-home IV therapy. IV treatment also improves wellness and good health. The IV drop, which contains minerals, water, and vitamins, can assist the patient in maintaining a healthy lifestyle and boosting his or her immune system. It also keeps the patient hydrated and increases their energy levels. In-home IV therapy has grown in popularity as a viable alternative to hospitalization as demand for hospital beds has increased and waiting lines have become interminable.

Furthermore, numerous healthcare facilities provide IV therapy as an alternative to hospitalization for patients on long-term drugs. For example, Pasithea Therapeutics Corp., a major biotechnology business, has developed Pasithea Clinics, a subsidiary that will provide in-home IV ketamine therapy to patients suffering from treatment-resistant mental health conditions. Because individuals with mental health illnesses have a hard time competing with normal routines, the minor step of in-home IV therapy is expected to reduce their stress and allow them to get therapy in the privacy of their own home.

The Market for intravenous (IV) therapy and vein access devices in Latin America is rapidly expanding. Brazil, Mexico, and Argentina are among the countries in this region that are enjoying strong economic expansion. The regional Market is characterized by the rising prevalence of chronic diseases such as cancer and diabetes.

The Market for intravenous (IV) therapy and vein access devices in the Middle East and Africa is rapidly expanding. Saudi Arabia, South Africa, and Nigeria are among the countries in this area that are enjoying strong economic expansion. Because of the rising prevalence of chronic diseases such as cancer and diabetes, intravenous (IV) therapy and vein access devices are becoming more popular across the Middle East and Africa. Higher incidence of chronic diseases such as diabetes and cancer, expanding healthcare infrastructure, rising GDP, increased disposable income, and increased awareness of advanced therapies' availability in the region are some of the growth factors for the regional Market. Latin America's and the Middle East's and Africa's Market s are still in their infancy.

The Brazil Market dominated the LAMEA Intravenous (IV) Therapy and Vein Access Market by Country 2021, and is expected to continue to be a dominant Market till 2028; thereby, achieving a Market value of $554.2 million by 2028. The Argentina Market is estimated to grow at a CAGR of 8.4% during (2022-2028). Additionally, The UAE Market is expected to witness a CAGR of 7.6% during (2022-2028).

Based on End User, the Market is segmented into Hospitals, Ambulatory Surgical Center, and Clinics. Based on Application, the Market is segmented into Medication Administration, Blood Based Products, Nutrition & Buffer Solution, and Volume Expander. Based on Type, the Market is segmented into Intravenous Catheters, Infusion Pumps, Hypodermic Needles, Implantable Ports, and Others. Based on countries, the Market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The Market research report covers the analysis of key stakeholders of the Market. Key companies profiled in the report include B. Braun Melsungen AG, Medtronic PLC, Terumo Corporation, Fresenius SE & Co. KGaA, Cardinal Health, Inc., Pfizer, Inc., Teleflex, Inc., Baxter International, Inc., Smiths Group PLC, and AngioDynamics, Inc.

Scope of the Study

Market Segments Covered in the Report:

By End User

• Hospitals
• Ambulatory Surgical Center
• Clinics

By Application

• Medication Administration
• Blood Based Products
• Nutrition & Buffer Solution
• Volume Expander

By Type

• Intravenous Catheters
• Infusion Pumps
• Hypodermic Needles
• Implantable Ports
• Others

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• B. Braun Melsungen AG
• Medtronic PLC
• Terumo Corporation
• Fresenius SE & Co. KGaA
• Cardinal Health, Inc.
• Pfizer, Inc.
• Teleflex, Inc.
• Baxter International, Inc.
• Smiths Group PLC
• AngioDynamics, Inc.

Unique Offerings from the Publisher

• Exhaustive coverage
• The highest number of Market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free